Modeller, epidemiologist, economist at @LSHTM, visiting prof at @HKUniversity, previously at Public Health England. Interested in vaccines, infectious diseases.
London, UK
Joined March 2009
- Tweets112
- Following159
- Followers1K
- Likes215
Mark Jit retweeted
We asked a range of key decision-makers what they need to know to about potential new vaccines
The results were..... Alot, and WHO's Full Value of Vaccine Assessments framework helps
But FVVAs could be even more useful
Our new paper gives 3 ways FVVAs could be even better:
Mark Jit retweeted
Vaccines saved 154 million lives over past 50 years study in @TheLancet by @WHO & LSHTM experts estimates.
@MarkJit comments on the global success of the Expanded Programme on #Immunization (EPI) 🌍💉
More 👉bit.ly/4dzKt46
ALT "Vaccines have saved more lives than any other medical innovation in the last century, but there's still work to be done." Mark Jit, Professor of Vaccine Epidemiology, LSHTM
Mark Jit retweeted
Join #EUROGIN2024 for a pivotal session on 'One-Dose Vaccination: Evidence Gaps & Global Experiences' 💉Discuss dosing plans & advances in #hpvvaccine. with @markjit & @brisson__marc
ow.ly/gvIX50Qj7Zx
#hpvvirus #hpvcongress #hpvawareness #cervicalcancerawareness #Eurogin
(1/2) 15 modellers in 7 countries from projects Epipose and @ESCAPEpandemics reflect on lessons learnt from modelling the COVID-19 pandemic, in the specal COVID-19 issue from @Health_Affairs.
healthaffairs.org/doi/full/1…
Mark Jit retweeted
🆕 study in @GlobalHealthBMJ suggests introducing microarray patches into #immunisation programmes in LMICs could ⬇️ decrease #measles burden & prevent high treatment costs.
Find out more 👇
bit.ly/3SENs32
Mark Jit retweeted
Thanks to co-authors @mert0248, Edwin van Leeuwen, @VetSree, @markjit and @rozeggo!
Also for a fuller understanding of the cost-effectiveness of such vaccines check out our other paper, answering similar questions in a completely different setting! bmcmedicine.biomedcentral.co…
We are still far from reaching WHO's target of bringing HPV vaccines to 90% of girls before age 15. Excited by opportunities that 1-dose vaccine schedules offer to help bring HPV vaccines to more people. This paper led by @kiesha_prem is a key piece of evidence to inform this.
Our recently published global impact and cost-effectiveness employed comparative modelling to evaluate outcomes of 1-dose vs 2-dose HPV vaccination schedules @BMCMedicine doi.org/10.1186/s12916-023-0…
✨@EmilyAnnika @jflaprise @hadley_liza @AllisonPortnoy @markjit @cmmid_lshtm +++✨
SIAs reach more unvaccinated children but MCV2 is more efficient per dose at preventing measles cases. New @vaccineimpact DynaMICE measles modelling paper in @LancetGH from Megan Auzenbergs, Han Fu and others in @cmmid exploring optimal vaccine strategies: sciencedirect.com/science/ar…
Great that WHO's Full Value of Vaccines Assessment framework is now published in @BMCMedicine . This has been used by WHO + collaborators to assess many recent vaccines in development.
rdcu.be/df00V
Fantastic that @TheEconomist are highlighting the global disparities around HPV vaccine uptake as well as the opportunity we have to end cervical cancer as public health problem.
In 2020 cervical cancer killed 342,000 women 🌍
95% of cervical #cancer cases are caused by #HPV
@TheEconomist uses model by Kaja Abbas & @markjit to estimate successful global HPV #vaccine initiative could reduce cervical cancer deaths by 2.65m by 2030💉📉👇
I'm delighted and humbled by this news. The award is really a testament to the dedication of my colleagues at LSHTM and around the world. I am so grateful for your support, encouragement and inspiration throughout my journey. Thank you!
Congratulations to LSHTM’s @markjit for being elected a Fellow of @acmedsci 🎉
Mark joins 59 influential scientists from UK institutions awarded the prestigious fellowship this year, for helping advance biomedical & health science.🔬#AMSFellows2023
👉bit.ly/43bIRHP
Mark Jit retweeted
1) In our recent review we introduce what are economic costs and why they are used in health economic studies
@Downey1L @AnnaVassall @HITAP_Thailand @markjit
resource-allocation.biomedce…
This new collection we put together shows most RSV burden is in very young infants in KE and ZA. So new RSV vaccines and mAbs could be even more cost-effective in some LMICs than recognised. Results of tremendous work by @nicd_sa @KEMRI_Kenya @PATHtweets @LSHTM investigators.
Underlining the collections' findings on RSV burden @PSrikantiah and @findingpneumo discuss the data included in the collection and the scale of RSV burden. @gatesfoundation
bmcmedicine.biomedcentral.co…
Mark Jit retweeted
Research by Waterlow et al. finds that next-generation vaccines may offer a cost-effective intervention to reduce influenza burden in low-income countries with year-round seasonality.
@LSHTM @N_R_Waterlow
Read more about this modelling study here:
bmcmedicine.biomedcentral.co…
Mark Jit retweeted
The first paper for my PhD thesis is now available at @LancetGH! 🎉
Our modelling shows that introducing new #TB #vaccines are likely to have a substantial health impact in LMICs 🗺️🦠💉
From @lshtm_tbmod @LSHTM_TB @LSHTM_Vaccines @cmmid_lshtm @LSHTM
thelancet.com/journals/langl…
A successful GBS vaccine could create billions of $ in value and save 10,000s of lives each year, if prices allow equitable global access.
Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus. doi.org/10.1371/journal.pmed… @mert0248 @markjit @joylawn @LSHTM_GHECO @MARCH_LSHTM
Really important initiative by a brilliant group of modellers and other academics.
🔦Spotlight on the @cmmid_lshtm @gatesfoundation grant to support “Women in Modelling at LSHTM”
💪Giving us a deeper understanding of the barriers for women in infectious disease mathematical modelling so that we can work to address them.
👇
bit.ly/3ylBW1b
#IWD2023
Really important study looking at what-if scenarios about COVID-19 vaccination in Africa led by @yangliubeijing with great input from Africa CDC and other colleagues!
Modelling collaboration from @markjit @LSHTM @rozeggo @cmmid_lshtm @just_nonvignon @AfricaCDC @AnnaVassall @cap1024 et al. Assessing the impacts of COVID-19 vaccination programmes in 27 African countries: bmcmedicine.biomedcentral.co…
Mark Jit retweeted
@Anna_Carnegie and I are running a COVID-19 reflective session on the 28th of March for those involved in the UK modelling response.
We hope to provide a neutral space for participants to reflect on their experiences and make suggestions to improve future outbreak responses.
